Patents by Inventor Carmen Miguel GÓMEZ SÁNCHEZ

Carmen Miguel GÓMEZ SÁNCHEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition combining an anticonvulsant and a derivate of nicotinic acid
    Patent number: 9895362
    Abstract: The combination of gabapentin with lysine clonixinate (CLG) makes it possible to relieve neuropathic pain caused both by diabetic neuropathy and by an injury to the nerve. The CLG combination produces a synergy in the antiallodynic effect, when the allodynia has been generated by direct mechanical damage to nervous tissue or when it has been produced as a result of a diabetic pathology. The therapeutic effect of the CLG combination is 3 to 11 times greater than the effect of each of the drugs separately. The CLG combination is safe, because it shows no adverse effects on motor activity or alterations in neurological parameters nor damage to the liver or kidney.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: February 20, 2018
    Assignee: FARMACÉUTICOS RAYERE, S.A.
    Inventors: Graciela de los Ángeles Aguilera Suárez, Carmen Miguel Gómez Sánchez, Martha Rosaura Juárez Lora
  • PHARMACEUTICAL COMPOSITION COMBINING AN ANTICONVULSANT AND A DERIVATE OF NICOTINIC ACID
    Publication number: 20170151223
    Abstract: The combination of gabapentin with lysine clonixinate (CLG) makes it possible to relieve neuropathic pain caused both by diabetic neuropathy and by an injury to the nerve. The CLG combination produces a synergy in the antiallodynic effect, when the allodynia has been generated by direct mechanical damage to nervous tissue or when it has been produced as a result of a diabetic pathology. The therapeutic effect of the CLG combination is 3 to 11 times greater than the effect of each of the drugs separately. The CLG combination is safe, because it shows no adverse effects on motor activity or alterations in neurological parameters nor damage to the liver or kidney.
    Type: Application
    Filed: June 16, 2014
    Publication date: June 1, 2017
    Inventors: Graciela de los Ángeles AGUILERA SUÁREZ, Carmen Miguel GÓMEZ SÁNCHEZ, Martha Rosaura JUÁREZ LORA